The startup has developed a nasal clip that applies constant, hands-free pressure to the nasal side walls while delivering vasoconstrictive medication through pre-medicated sponges to control nosebleeds in both children and adults. This device enhances patient care by providing adjustable sizing and an optional facial cooling pack to constrict blood vessels and reduce inflammation.
Funding
$7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Nosebleeds are a common issue that can be difficult to manage effectively, often requiring time-consuming and sometimes painful interventions in clinical settings. Current treatment methods may rely on multiple hospital resources and can be distressing for patients, especially children.
Solution
NasaClip offers a hands-free device designed for the rapid and effective treatment of nosebleeds in various settings, including homes, clinics, and sports fields. The device utilizes a clip with two soft sponges to apply constant, adjustable pressure to the nasal sidewalls, promoting natural blood clotting. This method eliminates the need for manual pressure and reduces mess, offering a more comfortable and convenient solution for patients of all ages. The NasaClip can be used independently or with vasoconstrictive medication applied to the sponges to expedite the process.
Target Audience
The primary target audience includes individuals who experience frequent nosebleeds, parents of children prone to nosebleeds, healthcare professionals in emergency rooms and clinics, and athletic trainers.
Features
- Adjustable clip design to provide personalized pressure for effective nosebleed management
- Soft, comfortable sponges for intranasal application, minimizing discomfort
- Hands-free operation, allowing patients to remain active during treatment
- Suitable for use at home, in clinics, schools, and sports fields
- Can be used with or without additional vasoconstrictive medication
- FDA registered